Search

Your search keyword '"Sarah Betrian"' showing total 30 results

Search Constraints

Start Over You searched for: Author "Sarah Betrian" Remove constraint Author: "Sarah Betrian"
30 results on '"Sarah Betrian"'

Search Results

1. Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer

3. A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid Cancer

4. 5-fluorouracil with oxaliplatin and/or irinotecan for advanced sinonasal intestinal-type adenocarcinoma (ITAC)

5. PARa-aOrtic LymphAdenectomy in locally advanced cervical cancer (PAROLA trial): a GINECO, ENGOT, and GCIG study

6. Application en France des recommandations européennes 2021 sur le cancer de l’endomètre

7. Survival impact of histological response to neoadjuvant chemotherapy according to number of cycles in patients with advanced ovarian cancer

8. Supplementary Figure S1 from A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid Cancer

9. Supplementary Table S5 from A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid Cancer

10. Data from A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid Cancer

11. Management of patients with advanced epithelial ovarian cancer: a European survey

12. Impact of pattern of recurrence on post-relapse survival according to surgical timing in patients with advanced ovarian cancer

13. Management of Endometrial Cancer: French Society of Onco-Gynecology's Evaluation through a Delphi Survey

14. 2022-RA-787-ESGO ESGO guidelines on the management of endometrial cancer. Weaknesses and controversies in france and french-speaking switzerland. Results of a delphi survey

15. [Application in France of the 2021 European recommendations on endometrial cancer]

16. Concordance of laparoscopic and laparotomic peritoneal cancer index using a two-step surgical protocol to select patients for cytoreductive surgery in advanced ovarian cancer

17. Results of a 2021 French National Survey on Management of Patients with Advanced Stage Epithelial Ovarian Cancer

18. Effect of tumor burden and radical surgery on survival difference between upfront, early interval or delayed cytoreductive surgery in ovarian cancer

19. Performance of Multiparametric Functional Imaging to Assess Peritoneal Tumor Burden in Ovarian Cancer

20. Sicca Syndrome Induced by Immune Checkpoint Inhibitor Therapy: Optimal Management Still Pending

21. A Case of Hemophagocytic Lymphohistiocytosis Induced by Regorafenib

23. Comparison of SPECT-CT with intraoperative mapping in cervical and uterine malignancies

24. Improving patient selection for immuno-oncology phase 1 trials: External validation of six prognostic scores in a French Cancer Center

25. First-in-human phase I study of the microtubule inhibitor plocabulin in patients with advanced solid tumors

26. SFOG Campus, A new group is born!

27. Multicentre randomized phase II trial of olaparib as maintenance therapy in platinum-sensitive advanced endometrial carcinoma: The GINECO-UTOLA study

28. Xérostomie induite par anti-PD1/PDL1 : caractérisation clinique, immunohistochimique et proposition de prise en charge

29. Improving patient selection for immuno-oncology phase I trials: An external validation of five prognostic scores at Claudius Regaud Institute of Toulouse, Oncopôle (IUCT-O)

30. Severe Onycholysis and Eyelash Trichomegaly Following Use of New Selective Pan-FGFR Inhibitors

Catalog

Books, media, physical & digital resources